Immune Checkpoint Protein Expression Defines the Prognosis of Advanced Thyroid Carcinoma

BACKGROUND: Patients with advanced thyroid carcinoma (TC), such as anaplastic thyroid carcinoma (ATC), poorly differentiated thyroid carcinoma (PDTC), and locally advanced papillary thyroid carcinoma (PTC), have poor prognoses and require novel treatments. Immune checkpoint (ICP) inhibitors have dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yi, Yang, Yi-Chen, Shen, Cen-Kai, Ma, Ben, Xu, Wei-Bo, Wang, Qi-Feng, Zhang, Yan, Liao, Tian, Wei, Wen-Jun, Wang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094437/
https://www.ncbi.nlm.nih.gov/pubmed/35574031
http://dx.doi.org/10.3389/fendo.2022.859013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9094437/
https://www.ncbi.nlm.nih.gov/pubmed/35574031
http://dx.doi.org/10.3389/fendo.2022.859013

Ejemplares similares